drugset / Trial / NCT02586935
Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders
Phase 2
Completed
83 enrolled
Holland Bloorview Kids Rehabilitation Hospital
McMaster University · collabUnity Health Toronto · collabUniversity of Toronto · collabWestern University, Canada · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will examine the safety and efficacy of tideglusib vs. placebo for the treatment of core symptom domains in adolescents with Autism Spectrum Disorders
Timeline
- Start
- 2016-02-10
- Primary completion
- 2018-02-25
- Completion
- 2018-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tideglusib | Small molecule | 400 mg | Oral |
| Comparator | Tideglusib | Small molecule | 1000 mg | Oral |